We will be exhibiting our artificial pericardium prosthesis “PeriBeam®” at The 56th Annual Meeting of the Japanese Society for Cardiovascular Surgery (Chairman: Professor Matsumiya Goro, Department of Cardiovascular Surgery, Graduate School of Medicine, Chiba University, Saturday, February 21st to Monday, February 23rd, 2026, Venue: Makuhari Messe International Conference Center/Exhibition Hall 7). Explanations will be given using explanatory panels, etc. at the JMS booth.
https://www.congre.co.jp/jscvs2026/
For further details, please contact:
Tetsuya Nagao／TamaBio Co.,Ltd. (MSE, Managing Director/CEO)
Registered (Tokyo) : A Class 1 Medical Devices Manufacturer & Distributor
PMDA Approval (DuraBeam® and PeriBeam®) : Class IV Highly Managed Medical Device
FDA Regulation Number : 870.3470, Classification Product Code DXZ
FDA Registration Number : 3041851334
Mobile +81 80 1196 3206 / Tel +81 422 53 5051 / FAX +81 422 38 5091
https://tamabio.com/en/
402 2-2-18 Sakai Musashino-shi Tokyo 180-0022 Japan